Absci Corp. (ABSI)
11.07
+0.32
(+2.98%)
USD |
NASDAQ |
Oct 02, 16:00
10.97
-0.10
(-0.90%)
After-Hours: 06:59
Absci Price : 11.07 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 11.14 | 11.34 | 10.83 | 11.07 | 3.385M |
| Oct 01, 2026 | 10.80 | 11.27 | 10.55 | 10.75 | 4.609M |
| Sep 30, 2026 | 10.36 | 10.99 | 10.04 | 10.77 | 5.432M |
| Sep 29, 2026 | 9.59 | 10.18 | 9.485 | 10.14 | 3.424M |
| Sep 28, 2026 | 9.57 | 9.669 | 9.25 | 9.49 | 3.253M |
| Sep 25, 2026 | 10.49 | 10.50 | 9.68 | 9.74 | 3.207M |
| Sep 24, 2026 | 9.55 | 10.39 | 9.30 | 10.34 | 3.388M |
| Sep 23, 2026 | 10.51 | 10.62 | 9.47 | 9.745 | 4.721M |
| Sep 22, 2026 | 10.00 | 11.26 | 9.75 | 10.71 | 8.367M |
| Sep 21, 2026 | 10.06 | 10.15 | 9.50 | 9.82 | 4.559M |
| Sep 18, 2026 | 9.27 | 9.74 | 9.08 | 9.65 | 7.733M |
| Sep 17, 2026 | 8.295 | 9.83 | 8.285 | 9.27 | 8.666M |
| Sep 16, 2026 | 8.02 | 8.20 | 7.865 | 8.04 | 2.614M |
| Sep 15, 2026 | 8.055 | 8.07 | 7.79 | 7.94 | 2.342M |
| Sep 14, 2026 | 8.03 | 8.25 | 8.02 | 8.09 | 3.005M |
| Sep 11, 2026 | 8.42 | 8.57 | 8.11 | 8.21 | 1.966M |
| Sep 10, 2026 | 8.375 | 8.56 | 8.020 | 8.24 | 3.089M |
| Sep 09, 2026 | 8.89 | 9.02 | 8.625 | 8.65 | 2.035M |
| Sep 08, 2026 | 8.82 | 9.10 | 8.57 | 8.91 | 2.509M |
| Sep 04, 2026 | 8.69 | 9.03 | 8.65 | 8.82 | 2.150M |
| Sep 03, 2026 | 8.91 | 8.995 | 8.55 | 8.80 | 2.753M |
| Sep 02, 2026 | 8.90 | 9.23 | 8.36 | 8.80 | 2.952M |
| Sep 01, 2026 | 8.85 | 9.08 | 8.711 | 8.84 | 3.242M |
| Aug 31, 2026 | 8.67 | 9.09 | 8.620 | 9.04 | 5.263M |
| Aug 28, 2026 | 9.202 | 9.30 | 8.60 | 8.71 | 2.507M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Twist Bioscience Corp. | 188.67 |
| Prime Medicine, Inc. | 2.98 |
| Beam Therapeutics, Inc. | 24.50 |
| Moderna, Inc. | 190.01 |
| Tenax Therapeutics, Inc. | 1.98 |
Price Related Metrics
| PS Ratio | 1072.28 |
| Price to Book Value | 7.716 |
| Earnings Yield | -7.23% |
| Market Cap | 1.899B |